NFU Mutual UK Equity Fund CRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -6.4 | 18.6 | -10.9 | 4.1 | 3.7 | |
+/-Cat | -1.4 | 2.3 | 0.8 | -3.9 | -3.0 | |
+/-B’mrk | - | - | - | -3.6 | -4.5 | |
Category: UK Flex-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 20/11/2024 | GBX 150.96 | |
Day Change | -0.53% | |
Morningstar Category™ | UK Flex-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B84CF023 | |
Fund Size (Mil) 31/10/2024 | GBP 371.18 | |
Share Class Size (Mil) 20/11/2024 | GBP 205.58 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 31/01/2024 | 0.74% |
Investment Objective: NFU Mutual UK Equity Fund C |
To achieve a combination of capital growth and income which results in a total return, net of fees, greater than that of the FTSE All-Share Index over a rolling 5-year period, by investing in UK equities. The Fund will invest at least 80% and up to 100% in a diversified portfolio of company shares (equities) domiciled in the UK (or whose business activities are predominantly in the UK/the majority of their revenue is derived from the UK but which are domiciled or quoted on a market outside the UK). |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Adam Carroll 10/10/2020 | ||
Matthew Grimson 10/10/2020 | ||
Inception Date 03/12/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for NFU Mutual UK Equity Fund C | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.27 |
RELX PLC | Industrials | 3.97 |
GSK PLC | Healthcare | 3.76 |
Compass Group PLC | Consumer Cyclical | 3.65 |
Unilever PLC | Consumer Defensive | 3.49 |
Increase Decrease New since last portfolio | ||
NFU Mutual UK Equity Fund C |